Lancet Respiratory Medicine
Cohort Study
Real-Time Subphenotyping for ARDS and AHRF Achieves Feasibility Threshold
A multicenter US study demonstrates the ability to rapidly classify patients with acute respiratory distress syndrome into biological subphenotypes.
Lancet Respiratory Medicine
Cohort Study
ARDS Inflammatory Phenotypes Show Differential Mortality and Ventilation Response
A retrospective cohort study reveals distinct 60-day mortality rates and varied responses to lung-protective ventilation parameters across ARDS.
Lancet Respiratory Medicine
Cohort Study
Diabetes Worsens Bronchiectasis Outcomes, Increases Comorbidities and Infection Risk
A large registry analysis confirms diabetes significantly impacts disease severity, exacerbations, hospitalizations, and mortality in bronchiectasis.
Lancet Respiratory Medicine
Randomized Controlled Trial
Tezepelumab Reduces Oral Corticosteroid Use in Severe Asthma
A phase 3 trial demonstrates that tezepelumab significantly lowers daily oral corticosteroid dose in adults with severe, OCS-dependent asthma.